Search companies

Live

Tuesday, 17 November 2026 · 582 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

IMEXHS revenue rises 23% as AI tools enter live use, but software bookings fall

IMEXHS Limited (IME) · Health care

IME: $0.330 +3.13% · MC: $19M

IMEXHS reported quarterly revenue growth of 23% and year-to-date revenue growth of 19%, while year-to-date underlying EBITDA more than doubled from the prior corresponding period. Its scheduling and image-suggestion AI agents moved into live production, and a transcription agent reached production readiness; however, new software recurring revenue fell from the previous quarter and software ARR was flat as churn offset new contracts. Cash increased from the previous quarter, while debt declined.

Source announcements: 2026-10-28 10:27 to 2026-10-28 10:27 Sydney time
Story updated 2026-10-28 10:40 Sydney time
SourcesQuarterly Activities/Appendix 4C Cash Flow Report
Comments